- Forums
- ASX - By Stock
- IHL
- Ann: IHL-675A in vivo results for Inflammatory Bowel Disease
Ann: IHL-675A in vivo results for Inflammatory Bowel Disease, page-2
-
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online